Ensuring the Group's independence and long-term growth
To create long-term value, we diversify and manage the Group's financial reserves through listed and private markets, with a strong sense of responsibility. Our activities revolve around 7 main areas.
Activities
Direct Private Equity
Supporting growing SMEs
Private Debt
Providing quick and flexible financings
Private Equity Funds
Developing a diversified and balanced portfolio
Long-term Participations
Joining forces with visionaries
Finance
Building a solid, balanced portfolio adapted to the new global environment
Real Estate
Managing and optimizing direct and indirect real estate assets
Compliance & Operations
Ensuring regulatory compliance of the group’s investments and operations management
Boards of Directors
Discover the members who guide and bring long-term vision to the company
Responsible Capital Management Directors
![](https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-768x0-c-default.jpg 768w)
Thierry Mauvernay
Thierry Mauvernay
President, Delegate of the Board, Après-demain SA![Director, Private Equity Department, Debiopharm Investment S.A.](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-768x0-c-default.jpg 768w)
Alexandra Le Coz Sanchez
Alexandra Le Coz Sanchez
Vice President, Capital Management![Chief Investment Officer, Financial department, Debiopharm Investment S.A. Debiopharm-Samuel-Moulin](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-768x0-c-default.jpg 768w)
Samuel Moulin
Samuel Moulin
Director, Finance Department & Chief Investment Officer![](https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-320x0-c-default.png 320w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-512x0-c-default.png 512w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-542x0-c-default.png 542w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-768x0-c-default.png 768w)
Sébastien Beth
Sébastien Beth
CEO, S.I.GN Partenaires SA, Director, Private Equity Department![Director, Real Estate department, Debiopharm Investment S.A. Debiopharm-Benjamin-Favre](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-768x0-c-default.jpg 768w)
Benjamin Favre
Benjamin Favre
CEO, Next Immobilier SA, Director, Real Estate Departement![](https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-768x0-c-default.jpg 768w)
Sophie Marguerat
Sophie Marguerat
Director, Compliance & OperationsStrategic Committee
![](https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-768x0-c-default.jpg 768w)
Thierry Mauvernay
Thierry Mauvernay
President, Delegate of the Board, Après-demain SA![Chief Executive Officer, Debiopharm International S.A.](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-768x0-c-default.jpg 768w)
Valérie Calvayrac
Valérie Calvayrac
Asset Diversification Strategic Leader![Director, Private Equity Department, Debiopharm Investment S.A.](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-768x0-c-default.jpg 768w)
Alexandra Le Coz Sanchez
Alexandra Le Coz Sanchez
Vice President, Capital Management![Debiopharm-Committee-Arturo-Bris](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-768x0-c-default.jpg 768w)
Arturo Bris
Arturo Bris
Member![](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-768x0-c-default.jpg 768w)
Ferdinando Mercuri
Ferdinando Mercuri
Member![Debiopharm-Committe-Renaud-de-Planta](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-768x0-c-default.jpg 768w)
Renaud de Planta
Renaud de Planta
Member![Debiopharm-Committee-Charles-Ruggieri](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-768x0-c-default.jpg 768w)
Charles Ruggieri
Charles Ruggieri
Member![Debiopharm-Committee-Bertrand-Rambaud](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-768x0-c-default.jpg 768w)
Bertrand Rambaud